Technology Innovator Awards 2017

, Best Biopharmaceutical Company – Italy & Excellence Award for Industrial Research 2017 Anabasis is a private, Milan based, biopharmaceutical company dedicated to the development of innovative therapies for the eye. OFounded in 1999, Anabasis is owned by Dompé, one of the leading biopharmaceutical companies in Italy, focusing on the development of innovative therapeutic solutions for rare, often orphaned, diseases. Dompé became Anabasis’s parent company by acquiring 49% of its shares. Furthermore, Dompé acquired the worldwide rights for the development and the commercialization of NGF for NK. The firm’s initial focus was NGF (Nerve Growth Factor) for the treatment of diseases affecting both the anterior part of the eye, such as neurotrophic keratitis (NK) and dry eye, as well as the posterior part of Best for Intelligent Software Solutions 2017 - UK InPhase helps organisations run better. It’s the glue that binds a business together, enabling all levels of a business tomake better, faster decisions fromboard to individual. Company: Anabasis S.r.l Contact: Francesco Sinigaglia Contact Email: [email protected] Address: Via San Martino 12, Milan, 20122, Italy Phone: 0039 02 58383 the eye such as glaucoma. While NK is an orphan disease, glaucoma represents one of the largest potential market opportunity in ophthalmology. These diseases can lead to severe vision loss and blindness. Looking ahead, both firms will continue to grow and prosper as they seek to create innovative developments in this vital market. InPhase is a single toolkit providing everything you need to deliver an integrated Business Intelligence, Reporting and Enterprise wide performance management solution for actionable change. To provide clients with the solution they need, InPhase conceived an approach to maximise the effectiveness of business decision making, to create the modern responsive, agile business. It started with the ability to unite your teams and individuals with the key drivers that matter to the enterprise. This included alignment with strategy, tactical and operational intent, risks, project management and actions. The result enabled enterprise wide collaboration to achieve collective ambition, pushing out wasted effort and activity. Two decades later, InPhase leads the way in delivering this vision AND unifies it with transaction data, giving your users integrated access to disparate internal and external data from a plethora of sources. Overall, this united product gives your users past, present and predicted outturn information from transaction to helicopter level. Users can model what-if, enabling them to make better decisions based on fact and process, faster. You can request a brochure, ask for case studies or simply book in for an on line demo by contacting InPhase. You can also request a trial version of the latest and easiest way to share information around your performance directly to the public direct from InPhase. To learn more on their latest innovation, visit the InPhase open data site at http://portal.inphase.com/ Contact: Victoria Keogh Contact Email: [email protected] Address: 2-4 Packhorse Road, Gerrards Cross, Buckinghamshire, SL9 7QE, UK Phone: 01753 480480